FDA Import Refusal 98F-0075223-6/11/4 — The Procter & Gamble Company
The FDA refused shipment 98F-0075223-6/11/4 from The Procter & Gamble Company (United States) on December 31, 2022. The refused product falls under Drugs and Biologics — CETYLPYRIDINIUM CHLORIDE (ANTI-INFECTIVE, TOPICAL). Cited charges: 2020,335,336,483 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- December 31, 2022
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62FBL07 CETYLPYRIDINIUM CHLORIDE (ANTI-INFECTIVE, TOPICAL)
- Charges
- 2020,335,336,483